Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl)benzoic Acid
2. Abbv-2222
3. Glpg2222
1. Abbv-2222
2. 1918143-53-9
3. Galicaftor [inn]
4. Galicaftor [usan]
5. Glpg2222
6. Glpg-2222
7. J0iit8qsqs
8. 4-[(2r,4r)-4-({[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl]benzoic Acid
9. Benzoic Acid, 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-1-benzopyran-2-yl)-
10. 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl)benzoic Acid
11. Unii-j0iit8qsqs
12. Galicaftor (usan/inn)
13. Galicaftor [who-dd]
14. Chembl4101487
15. Schembl17708714
16. Ex-a6713
17. S8535
18. Who 10837
19. Abbv-2222 (glpg2222)
20. Db14894
21. Hy-111111
22. Cs-0034251
23. D11724
24. Q29208499
25. 4-[(2r,4r)-4-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl]benzoic Acid
| Molecular Weight | 559.5 g/mol |
|---|---|
| Molecular Formula | C28H21F4NO7 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 559.12541466 g/mol |
| Monoisotopic Mass | 559.12541466 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 957 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Galicaftor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galicaftor, including repackagers and relabelers. The FDA regulates Galicaftor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galicaftor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Galicaftor supplier is an individual or a company that provides Galicaftor active pharmaceutical ingredient (API) or Galicaftor finished formulations upon request. The Galicaftor suppliers may include Galicaftor API manufacturers, exporters, distributors and traders.
Galicaftor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Galicaftor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Galicaftor GMP manufacturer or Galicaftor GMP API supplier for your needs.
A Galicaftor CoA (Certificate of Analysis) is a formal document that attests to Galicaftor's compliance with Galicaftor specifications and serves as a tool for batch-level quality control.
Galicaftor CoA mostly includes findings from lab analyses of a specific batch. For each Galicaftor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Galicaftor may be tested according to a variety of international standards, such as European Pharmacopoeia (Galicaftor EP), Galicaftor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galicaftor USP).
LOOKING FOR A SUPPLIER?
